Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Da Yuan Yin
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Shuang Huang Lian Kou Fu Ye
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Bu Huan Jin Zheng Qi San
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Novaferon
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/29/2020
FX06
Potential treatment - clinical evidence Experimental Other treatment Sep/24/2020
Glucocorticoids
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Moxifloxacin
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/05/2020
Human amnionic fluid
Potential treatment - clinical evidence Experimental Other treatment Jan/22/2021
Shufeng Jiedu
Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020
Acetylsalicylic acid
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Emtricitabine
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Fluvoxamine
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/27/2021
Metformin
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/14/2021
IVIg
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Itolizumab
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Ozone
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/22/2021
Bamlanivimab
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
EXO-CD24
Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022